Thursday, March 04, 2021 9:10:34 AM
But CEO Holmes is not serving his shareholders. Holmes is ghosting the investors who funded his business and his salary for over 15 years. That's disrespectful, IMO, and not acceptable for a publicly traded company.
* Update the clinicaltrials.gov page.
* Get the financial statements up to date.
* Release a PR explaining the current status of: clinicals, FDA submissions, funding, the application, and the server.
Total cost: a few hundred dollars and a few days of effort. What's stopping you, Jim? Too busy inking deals? LOL
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM